UBS Maintains Neutral on GE HealthCare Techs, Raises Price Target to $80

Benzinga · 4d ago
UBS analyst Graham Doyle maintains GE HealthCare Techs (NASDAQ:GEHC) with a Neutral and raises the price target from $73 to $80.